Harnessing Placebo Effects for the Treatment of Functional Cognitive Disorder: A Feasibility Pilot Study
Authors:
- Matthew J. BurkeMBMatthew J. Burke
- Davide CapponDCDavide Cappon
- David L. PerezDPDavid L. Perez
- Alvaro Pascual-LeoneAPAlvaro Pascual-Leone
- Emiliano SantarnecchiESEmiliano Santarnecchi
- 1 July 2024
- journal article
- research article
- Published by American Psychiatric Association Publishing in The Journal of Neuropsychiatry and Clinical Neurosciences
- Vol. 36 (3) , 214-219
Abstract
Objective: Limited research has directly investigated whether and how placebo effects can be harnessed for the treatment of functional neurological disorder (FND), despite a long-standing and controversial history of interest in this area. Methods: A small exploratory study was conducted with adults with a cognitive subtype of FND recruited from a single cognitive neurology center in the United States. Participants were given the expectation of receiving cranial stimulation that could benefit their memory symptoms; however, the intervention was sham transcranial magnetic stimulation (placebo). Outcomes included measures of short-term memory testing, subjective memory rating, and state anxiety before and after stimulation. After the study, the true objective and rationale for investigating placebo effects were explained in a scripted debriefing session. Acceptability of the study design and qualitative feedback were collected. Institutional ethics approval and signed consent were obtained. Results: Three patients (female, N=2; male, N=1; average age=57 years) were recruited. Outcome data were analyzed descriptively at the patient level. Trends of improvement in subjective memory rating, but not objective cognitive test scores, and decreases in state anxiety were observed. After the debriefing session, all patients found the study design to be acceptable (ratings of 70%, 90%, and 100%), and two of the three patients believed that withholding mechanistic information about the intervention was needed to leverage placebo effects as treatment. Conclusions: In the first study to prospectively investigate the feasibility of harnessing placebo effects for the treatment of FND, promising preliminary findings were obtained, and methods and resources for use in larger future studies are offered.Keywords
This publication has 17 references indexed in Scilit:
- Functional cognitive disorders: a systematic reviewThe Lancet Psychiatry, 2020
- Leveraging the Shared Neurobiology of Placebo Effects and Functional Neurological Disorder: A Call for ResearchThe Journal of Neuropsychiatry and Clinical Neurosciences, 2020
- Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extensionJournal of Neurology, Neurosurgery & Psychiatry, 2019
- Challenges of differential placebo effects in contemporary medicine: The example of brain stimulationAnnals of Neurology, 2018
- Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?BMJ, 2018
- The role of placebo in the diagnosis and treatment of functional neurologic disorders2016
- The neuroscience of placebo effects: connecting context, learning and healthNature Reviews Neuroscience, 2015
- Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in AsthmaNew England Journal of Medicine, 2011
- Placebo-mediated, Naloxone-sensitive suggestibility of short-term memory performanceNeurobiology of Learning and Memory, 2011
- The Syndrome of Functional Memory Disorder: Definition, Etiology, and Natural CourseThe American Journal of Geriatric Psychiatry, 2008